Form D · Private Equity Fund

Cormorant Private Healthcare Fund VI, LP

Boston, MA · CIK 0002098185

Offering snapshot reported Jun 25, 2026 · SEC filing

Reported sold
$176M
Offering amount: $176M
Investors reported
56
Form D · investor count
Minimum accepted
$5M
Reported outside-investor minimum
First sale
Nov 10, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$87.8M$176MNov 25, 2025: $75,200,000.00Nov 25, 2025Jun 25, 2026: $175,550,000.00Jun 25, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$75,200,000 → $175,550,000
  • Reported investors20 → 56

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 25, 2026Amendment$175,550,000$100,350,000vs Nov 25, 202556SEC filing
Nov 25, 2025Initial$75,200,000No comparison20SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-565060

Source: Form D, filed Jun 25, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CORMORANT PRIVATE HEALTHCARE FUND VI, LP

Investment adviser: CORMORANT ASSET MANAGEMENT, LP

Gross asset value
$103M
Beneficial owners
26
ADV minimum commitment
$5M

Reported in Form ADV on May 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STONE COAST FUND SERVICES PORTLAND, Maine, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor DELOITTE & TOUCHE LLP BOSTON, Massachusetts, United States
Custodian GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No
Prime broker GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

DELOITTE & TOUCHE LLP
PCAOB 34

GOLDMAN SACHS & CO. LLC
SEC 8-129

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

Filing source

Form ADV 2108497 · May 27, 2026 · Schedule D 7.B.(1), fund 805-6819069301

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bihua Chen Executive, Promoter
N/A Cormorant Asset Management, Lp Executive, Promoter
N/A Cormorant Private Healthcare Gp Vi Llc Executive, Promoter
Caleb Tripp Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
200 Clarendon Street 50th Floor
Boston, MA, 02116